Treatment progress and literature review of sepsis-associated thrombocytopenia
10.3969/j.issn.1008-9691.2024.03.026
- VernacularTitle:脓毒症相关性血小板减少症的治疗进展并文献复习
- Author:
Qiaohong WANG
1
;
Xingxing CHEN
;
Yongpo JIANG
Author Information
1. 台州恩泽医疗中心(集团)恩泽医院急诊科,浙江台州 318000
- Keywords:
Sepsis;
Platelets;
Immunity;
Inflammation;
Prognosis
- From:
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care
2024;31(3):371-374
- CountryChina
- Language:Chinese
-
Abstract:
Sepsis is the main cause of infection death in intensive care unit(ICU),and thrombocytopenia is a common complication.Persistent thrombocytopenia is a marker of poor prognosis in critically ill patients.Sepsis-associated thrombocytopenia(SAT)involves a variety of pathophysiological mechanisms,and platelets play a key role in coagulation and inflammatory response.Platelet count(PLT)can not only predict the prognosis of patients with sepsis,but also be used as a therapeutic target to improve the success rate of rescue in patients with sepsis.This article will review the pathophysiological mechanism,prognosis and treatment of platelets in septic patients.